These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4217979)

  • 1. [Influencing of blood sugar, serum insulin level and nonesterified fatty acids during continuous feeding following orally administered sulfonylurea compounds ARDF 26 and glibenclamide].
    Zilker T; Waldthaler A; Lüders T; Ermler R; Bottermann P
    Verh Dtsch Ges Inn Med; 1974; 80():1299-302. PubMed ID: 4217979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action of gliquidone (author's transl)].
    Zilker T; Ermler R; Henderkott U; Bottermann P
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of gliquidone and glibenclamide following oral administration].
    Ziler T; Waldthaler A; Ermler R; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
    Herrlinger H; Dörfler H; Wolfram G; Zöllner N
    Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical and biochemical study of 12 cases of acromegaly with special reference to plasma I.R.I. and FFA on glibenclamide administration.
    Kumar V; Gulatia RK; Ahuja MM
    J Assoc Physicians India; 1971 Sep; 19(9):623-7. PubMed ID: 5005675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of blood sugar, serum insulin and free fatty acids following tolbutamide and glibenclamide in subjects of normal metabolism, pretreated with alpha and beta receptor blockaders].
    Haupt E; Cordes U; Köberich W; Beyer J; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():1072-6. PubMed ID: 5005542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on dose-response relationship of various sulfonylurea derivatives of the old and the new generation with further hints to extrapancreatic mechanisms of decreasing blood sugar].
    Haupt E; Köberich W; Cordes U; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2203. PubMed ID: 4198968
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 14. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
    Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties.
    Rosak C; Haupt E; Beyer J; Schöffling K
    Horm Metab Res; 1974 Nov; 6(6):464-70. PubMed ID: 4217757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.